Criteria for Evaluating Multi-cancer Early Detection Tests
Authors:
- Glenn D BraunsteinGBGlenn D Braunstein
- Joshua J OfmanJOJoshua J Ofman
- Inc. GrailIGInc. Grail
Open Access
- 1 January 2021
- journal article
- research article
- Published by Touch Medical Media, Ltd. in Oncology & Haematology
- Vol. 17 (1)
Abstract
Somatic DNA mutational analysis has transformed how we characterize existing cancer and select treatments. For example, circulating tumour cell-free DNAKeywords
Funding Information
- This article is published under the Creative Commons Attribution Non-commercial License.
This publication has 31 references indexed in Scilit:
- Detection and localization of surgically resectable cancers with a multi-analyte blood testScience, 2018
- National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance ConsortiumRadiology, 2017
- Screening for Colorectal CancerJAMA, 2016
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2016
- Performance of Lung-RADS in the National Lung Screening TrialAnnals of Internal Medicine, 2015
- Results of Initial Low-Dose Computed Tomographic Screening for Lung CancerNew England Journal of Medicine, 2013
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLOS Medicine, 2012
- American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010CA: A Cancer Journal for Clinicians, 2010
- Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer ScreeningThe Annals of Family Medicine, 2009
- TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective StudyCancer Research, 2006